Early bronchodilating effect of a new oral beta-2-receptor agonist (broxaterol) in bronchial asthma. 1988

A Chetta, and G Garavaldi, and A Cuomo, and G Gurrieri, and D Olivieri
Istituto di Clinica delle Malattie dell'Apparato Respiratorio dell'Università di Parma, Italia.

In order to determine the bronchodilating activity and safety of two beta-2-receptor agonists, broxaterol and procaterol, compared with a placebo, 12 patients with reversible airway obstruction were tested in a double-blind cross-over study. The drugs were administered orally and the dosage of broxaterol was 0.5 mg, that of procaterol 0.05 mg. Measurements of forced expiratory volume in 1 s (FEV1), heart rate and blood pressure were performed before and 30, 60, 120, 240, 360, and 480 min after each treatment. Both drugs produced bronchodilation but broxaterol was statistically 30 min faster in producing this effect than procaterol (p less than 0.05). Moreover this effect for both drugs persisted significantly for up to 480 min compared with the effect of the placebo (p less than 0.005). There were no significant side effects with either drug. Heart rate and blood pressure did not show any changes in clinical significance for broxaterol or procaterol. In our study, broxaterol showed a faster bronchodilating effect than procaterol, and tolerance was the same for both drugs.

UI MeSH Term Description Entries
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000318 Adrenergic beta-Agonists Drugs that selectively bind to and activate beta-adrenergic receptors. Adrenergic beta-Receptor Agonists,beta-Adrenergic Agonists,beta-Adrenergic Receptor Agonists,Adrenergic beta-Agonist,Adrenergic beta-Receptor Agonist,Betamimetics,Receptor Agonists, beta-Adrenergic,Receptors Agonists, Adrenergic beta,beta-Adrenergic Agonist,beta-Adrenergic Receptor Agonist,Adrenergic beta Agonist,Adrenergic beta Agonists,Adrenergic beta Receptor Agonist,Adrenergic beta Receptor Agonists,Agonist, Adrenergic beta-Receptor,Agonist, beta-Adrenergic,Agonist, beta-Adrenergic Receptor,Agonists, Adrenergic beta-Receptor,Agonists, beta-Adrenergic,Agonists, beta-Adrenergic Receptor,Receptor Agonist, beta-Adrenergic,Receptor Agonists, beta Adrenergic,beta Adrenergic Agonist,beta Adrenergic Agonists,beta Adrenergic Receptor Agonist,beta Adrenergic Receptor Agonists,beta-Agonist, Adrenergic,beta-Agonists, Adrenergic,beta-Receptor Agonist, Adrenergic,beta-Receptor Agonists, Adrenergic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Chetta, and G Garavaldi, and A Cuomo, and G Gurrieri, and D Olivieri
January 1987, Respiration; international review of thoracic diseases,
A Chetta, and G Garavaldi, and A Cuomo, and G Gurrieri, and D Olivieri
January 1990, International journal of clinical pharmacology research,
A Chetta, and G Garavaldi, and A Cuomo, and G Gurrieri, and D Olivieri
January 1989, Respiration; international review of thoracic diseases,
A Chetta, and G Garavaldi, and A Cuomo, and G Gurrieri, and D Olivieri
October 1991, European journal of pharmacology,
A Chetta, and G Garavaldi, and A Cuomo, and G Gurrieri, and D Olivieri
January 1974, Polski tygodnik lekarski (Warsaw, Poland : 1960),
A Chetta, and G Garavaldi, and A Cuomo, and G Gurrieri, and D Olivieri
June 1985, The Journal of allergy and clinical immunology,
A Chetta, and G Garavaldi, and A Cuomo, and G Gurrieri, and D Olivieri
January 1990, International journal of clinical pharmacology research,
A Chetta, and G Garavaldi, and A Cuomo, and G Gurrieri, and D Olivieri
January 2007, Acta medica Indonesiana,
A Chetta, and G Garavaldi, and A Cuomo, and G Gurrieri, and D Olivieri
February 1987, JAMA,
A Chetta, and G Garavaldi, and A Cuomo, and G Gurrieri, and D Olivieri
November 1993, Ugeskrift for laeger,
Copied contents to your clipboard!